Australia's Optiscan Imaging rises on deal with Australian Clinical Labs

Optiscan Imaging

10/11/2025 02:47

** Shares of Australia's Optiscan Imaging OIL.AX rises 13.6% to A$0.125, their highest since October 30

** Optiscan Imaging partners with Australian Clinical Labs ACL.AX partners to support deployment and testing of its InForm digital pathology platform

** Optiscan says it will test the InForm digital pathology device within ACL's flagship anatomical pathology laboratory in Western Australia

** ACL rises 2.2% to A$2.605, but down 24.3% YTD

** OIL stock down 18.8%, YTD

 (Reporting by Keshav Singh Chundawat in Bengaluru)

 ((Keshav.singhchundawat@thomsonreuters.com))